Regulation of Burn Skin Regeneration on ERK1/2 and p38 Signaling Pathway Molecules in Diabetic Foot

吴标良,唐乾利,覃晓洁,冯烈,王民登,何明杰,吕震
DOI: https://doi.org/10.3969/j.issn.1007-9572.2015.29.021
2015-01-01
Chinese General Practice
Abstract:Objective To investigate the regulation of moist exposed burn therapy/ moist exposed burn ointment (MEBT/ MEBO)on the expression of ERK1 / 2 and p38 signaling pathway molecules in diabetic foot and to study the repair mechanism of MEBT/ MEBO therapy on diabetic foot ulcer. Methods We enrolled 40 patients who were definitely diagnosed with T2DM and diabetic foot in the Endocrinology Department of the Affiliated Hospital of Youjiang Medical University for Nationalities and the First Affiliated Hospital of Guangxi University of Chinese Medicine from January 2013 to June 2014. The patients were all administrated with wound surface treatment by MEBT/ MEBO operating process and were administrated with MEBO treatment. The muscle granulation tissue was taken before and after treatment,immuno - histochemistry was undertaken to measure the expression of key molecules of ERK1 / 2 and p38 signaling pathways,including ERK1 / 2,p38,MAPKK6,c -myc,Akt and ATF2. Results After MEBT/ MEBO treatment,14(35. 0% ) patients saw obvious efficacy,25(62. 5% ) saw efficacy,and 1(2. 5% )saw no efficacy,with a total effective rate of 97. 5% (39 / 40). The positive expression rates of signaling molecules( any signaling molecule) after treatment were significantly different from those before treatment( P ﹤0. 001);the positive expression rates of signaling molecules,such as ERK1 / 2,p38,MAPKK6 and its substrate c - myc,Akt and ATF2 after treatment were significantly different from those before treatment( P ﹤ 0. 001). The immuno - histochemical pathology results showed that the signaling molecules had diffusive distribution on wound surface before treatment,and the distribution area became more extensive after treatment. Conclusion MEBT/ MEBO can promote the healing of diabetic foot ulcer,the mechanism may be that it is involved in the regulation of ERK1 / 2 and p38 signaling pathways.
What problem does this paper attempt to address?